Analyst Expects Cabaletta Bio Inc (NASDAQ: CABA) To Make Big Moves

After Hours

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Earlier, Yahoo Finance discussed this stock as it revealed Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

As a NASDAQ listed company, CABA falls under the Healthcare sector while operating within the Biotechnology industry segment. At the end of the last regular session, the stock closed at $23.59 and fluctuated between $23.98 as its day high and $22.42 as its day low. The current market capitalization of Cabaletta Bio Inc is $1.01B. A total of 0.93 million shares were traded on the day, compared to an average of 1.28M shares.

Insider Activity

Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, CABA has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 6 BUYs and 10 SELLs from insiders. Insiders purchased 77,000 shares during that period but sold 77,000.

In the most recent transaction, Binder Gwendolyn sold 11,000 shares of CABA for 19.59 per share on Jan 19. After the transaction, the insider now owns 20,000 company shares. In a previous transaction on Dec 19, Binder Gwendolyn sold 11,000 shares at 21.89 per share. CABA shares that the insider owns now total 20,000.

Among the insiders who sold shares, Binder Gwendolyn disposed of 11,000 shares on Nov 20 at a per-share price of $17.82. This resulted in the insider holding 20,000 shares of CABA after the transaction. In another insider transaction, Binder Gwendolyn sold 11,000 shares at $13.36 per share on Oct 19. Company shares held by the insider now total 20,000.

In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for CABA in the last 3 months, the mean price target is $32.44 with high estimates of $50.00 and low estimates of $25.00. In terms of 52-week highs and lows, CABA has a high of $24.62 and a low of $5.88.

As of this writing, CABA has an earnings estimate of $CAVA Group, Inc. per share for the current quarter. EPS was calculated based on a consensus of Alibaba Group Holding Limited estimates, with a high estimate of $Casa Systems, Inc. per share and a lower estimate of $Cara Therapeutics, Inc..

Balance Sheet Annually/Quarterly

The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. CABA’s latest balance sheet shows that the firm has $122.22M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $8.38M in liabilities at the time. Its Book Value Per Share was $3.86, while its Total Shareholder’s Equity was $117.96M.

Analysts Opinion

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CABA is Buy with a score of 5.00.

Most Popular

Related Posts